NCT02620657

Brief Summary

Approximately 3000 advanced NSCLC patients, who fulfil the inclusion/exclusion criteria, will be recruited by 30 sites in North China.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,809

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 1, 2015

Completed
Same day until next milestone

Study Start

First participant enrolled

December 1, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 3, 2015

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 8, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 8, 2017

Completed
Last Updated

August 2, 2019

Status Verified

August 1, 2019

Enrollment Period

1.9 years

First QC Date

December 1, 2015

Last Update Submit

August 1, 2019

Conditions

Non-Small Cell Lung Cancer

Outcome Measures

Primary Outcomes (1)

  • To investigate the proportion of advanced NSCLC patients who performed EGFR mutation test

    2014.01.01-2014.12.31

Study Arms (1)

Non interventional study

The patients with advanced NSCLC who have the medical records from Jan 1st 2014 to Dec 31st 2014 will be recruited .

Other: Non interventional study

Interventions

Non interventional studyOTHER

Non interventional study

Non interventional study

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

3000 advanced NSCLC patients

You may qualify if:

  • Histological or cytological confirmed NSCLC;
  • Patients were diagnosed with advanced NSCLC from Jan 1st 2014 to Dec 31st 2014;
  • Researchers should collect the records of consecutive NSCLC patients in each site.

You may not qualify if:

  • Any patients without NSCLC diagnosis;
  • Any patients which were diagnosed with advanced NSCLC before Jan 1st 2014 or after Dec 31st 2014.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Carcinoma, Non-Small-Cell Lung

Condition Hierarchy (Ancestors)

Carcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • CHENG NA Ying, Dr.

    Jilin Provincial Tumor Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Director of Jilin Cancer Hospital

Study Record Dates

First Submitted

December 1, 2015

First Posted

December 3, 2015

Study Start

December 1, 2015

Primary Completion

November 8, 2017

Study Completion

November 8, 2017

Last Updated

August 2, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share